Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L18a pseudogene 13 (RPL18AP13) is a processed pseudogene related to the functional ribosomal protein L18a gene (RPL18A). It does not encode a functional protein. Pseudogenes like RPL18AP13 arise from gene duplication or retrotransposition and are typically non-functional; they may be transcribed but are not translated into active ribosomal proteins. RPL18AP13 does not participate in ribosomal function or known cellular pathways, nor is it associated with therapeutic drug targeting or disease involvement. The RPL18AP13 entry is designated as a pseudogene in major gene databases. Pseudogenes do not produce functional proteins and are generally not therapeutic targets. There are no described roles in diseases, no known biological functions, and no known drug interactions for this pseudogene. The functional form, RPL18A, encodes a ribosomal protein essential for protein synthesis as part of the 60S ribosomal subunit, but RPL18AP13 is not the functional gene; it is one of a set of non-coding pseudogenes derived from RPL18A.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L18a pseudogene 13 (RPL18AP13).